Homing in on genomic instability as a therapeutic target in cancer
While genomic instability is a hallmark of cancer, its genetic vulnerabilities remain poorly understood. Identifying strategies that exploit genomic instability to selectively target cancer cells is a central challenge in cancer biology with major implications for anti-cancer drug development.
Guardado en:
Autores principales: | Craig M. Bielski, Barry S. Taylor |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/05aa6b75dc3d45a196bcacb216f9a997 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Genomic instability in mutant p53 cancer cells upon entotic engulfment
por: Hannah L. Mackay, et al.
Publicado: (2018) -
Multiple signaling kinases target Mrc1 to prevent genomic instability triggered by transcription-replication conflicts
por: Alba Duch, et al.
Publicado: (2018) -
The presence of extra chromosomes leads to genomic instability
por: Verena Passerini, et al.
Publicado: (2016) -
3D genome organization contributes to genome instability at fragile sites
por: Dan Sarni, et al.
Publicado: (2020) -
Genomic characterization of genes encoding histone acetylation modulator proteins identifies therapeutic targets for cancer treatment
por: Zhongyi Hu, et al.
Publicado: (2019)